Back to discover
Drug
Lysophosphatidic acid
Research stageEmerging research
1
Research papers
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this drug.
Altered cortical synaptic lipid signaling leads to intermediate phenotypes of mental disorders.
Research2024-05-28Molecular psychiatry
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Canonical name
Lysophosphatidic acid
RxNorm CUI
1793921
ChEMBL ID
CHEMBL1222042
UNII
PG6M3969SG
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Most influential
Major research themes4
Lysophospholipids1Mental Disorders1Phenotype1Phosphoric Diester Hydrolases1
Journals, researchers & institutions
Top journals
- Molecular psychiatry1
Leading researchers
- Baumgart J1
- Dannlowski U1
- Daun S1
- Endle H1
- Götz J1
- Grabe HJ1
- Groppa S1
- Groß J1
Leading institutions
free-text, unnormalised
- Department SHIP/Clinical Epidemiological Research1
- Institute for Biomagnetism and Biosignalanalysis1
- Institute for Molecular Biology Mainz1
- Institute for Translational Neuroscience1
- Institute for Translational Psychiatry1
- Institute of Anatomy1
References & data sources
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature